Research & Development
18 March 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) on Monday revealed significant overall survival (OS) data from RUBY phase III trial, indicating the potential of Jemperli (dostarlimab...
18 March 2024 - ImmVira, a biotechnology company focused on developing and synthesising a biological vector delivery platform, announced on Friday that it has received Fast Track designation from the ...
15 March 2024 - Syngene International, a global contract research, development and manufacturing organization (CRDMO), announced on Thursday that its newly upgraded biologics facility - Unit three - i...
15 March 2024 - Biopharmaceutical company BioXcel Therapeutics Inc (Nasdaq:BTAI) announced on Friday that it has been granted a European patent covering the use of dexmedetomidine administered subling...
14 March 2024 - Poseida Therapeutics, Inc. (Nasdaq: PSTX), a California-based clinical-stage cell and gene therapy company, announced on Wednesday that it has received Orphan Drug Designation from the...
14 March 2024 - Swedish orthobiologics company Bonesupport Holding AB (STO:BONEX) announced on Thursday that the US Food and Drug Administration (FDA) has cleared CERAMENT G for use in open fractures....